top of page
Sucess Story

Trans-National Access in TRANSVAC2, so far...

TRANSVAC2 offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease area. Services are offered free of charge, with few exceptions. Academic and non-academic research groups, SMEs and industries can apply to access such support.  


So far (mid-2021) TRANSVAC2 had 11 TNA open calls, which received a total of 86 applications, with a success rate of approx. 60% of all projects being granted.

Total applications_210615.png
Success rate_210615.png

What are the most sought after services?

Applicants apply preferentially for services within the Technology and Animal models platform. There is also significant demand for TNA7 services, Immunocorrelates and Systems Biology

Demand Platforms_210615.png
Demand TNA Services_210615.png

Immunocorrelates & Systems Biology

Animal models

Cross-Platform screening & Optimisation services

Adjuvants & Delivery systems

Analytical Services

Pre-clinical GLP Production services

Structural Biology

Clinical Trial & Regulatory Support

Who applies for TRANSVAC2 TNA Services?

Members of the research community worldwide can apply for TRANSVAC2 support. As per the eligibility criteria, 20% of TRANSVAC2 support can be provided to applicants from non-EU countries. 

Applicants provenence_210615.png
Applicant's gender_210615.png

What is the scope of the granted projects?

Projects Vaccine Type_210615.png
Granted Projects Pathogenic agent target

Other can refer to adjuvant development, vaccine platforms and other technologies.

Last updated on 20.06.2021

bottom of page